Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn J Barst

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 3, 2002
Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imagingKenneth Nichols, Rola Saouaf, Ala'eldin A Ababneh, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 30, 2009
Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertensionLaura Rodriguez-Murillo, Ryan Subaran, William C L Stewart, et al.
Journal of the American College of Cardiology|July 24, 2012
Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension studyRonald J Oudiz, Bruce H Brundage, Nazzareno Galiè, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertensionRobyn J Barst, Dunbar Ivy, Jasper Dingemanse, et al.
Clinical Dysmorphology|November 18, 2008
Familial pulmonary arterial hypertension, leucopenia, and atrial septal defect: a probable new familial syndrome with multisystem involvementAli Dursun, R Koksal Ozgul, Asli Soydas, et al.
Mayo Clinic Proceedings|August 5, 2008
Design of the REVEAL registry for US patients with pulmonary arterial hypertensionMichael D McGoon, Abby Krichman, Harrison W Farber, et al.
Lancet (London, England)|January 14, 2012
Clinical features of paediatric pulmonary hypertension: a registry studyRolf M F Berger, Maurice Beghetti, Tilman Humpl, et al.
Journal of the American College of Cardiology|August 16, 2005
Effects of long-term bosentan in children with pulmonary arterial hypertensionErika Berman Rosenzweig, D Dunbar Ivy, Allison Widlitz, et al.
The American Journal of Cardiology|January 12, 2005
New predictors of outcome in idiopathic pulmonary arterial hypertensionSteven M Kawut, Evelyn M Horn, Ketevan K Berekashvili, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated evidence-based treatment algorithm in pulmonary arterial hypertensionRobyn J Barst, J Simon R Gibbs, Hossein A Ghofrani, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 3, 2002
Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imagingKenneth Nichols, Rola Saouaf, Ala'eldin A Ababneh, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 30, 2009
Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertensionLaura Rodriguez-Murillo, Ryan Subaran, William C L Stewart, et al.
Journal of the American College of Cardiology|July 24, 2012
Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension studyRonald J Oudiz, Bruce H Brundage, Nazzareno Galiè, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertensionRobyn J Barst, Dunbar Ivy, Jasper Dingemanse, et al.
Clinical Dysmorphology|November 18, 2008
Familial pulmonary arterial hypertension, leucopenia, and atrial septal defect: a probable new familial syndrome with multisystem involvementAli Dursun, R Koksal Ozgul, Asli Soydas, et al.
Mayo Clinic Proceedings|August 5, 2008
Design of the REVEAL registry for US patients with pulmonary arterial hypertensionMichael D McGoon, Abby Krichman, Harrison W Farber, et al.
Lancet (London, England)|January 14, 2012
Clinical features of paediatric pulmonary hypertension: a registry studyRolf M F Berger, Maurice Beghetti, Tilman Humpl, et al.
Journal of the American College of Cardiology|August 16, 2005
Effects of long-term bosentan in children with pulmonary arterial hypertensionErika Berman Rosenzweig, D Dunbar Ivy, Allison Widlitz, et al.
The American Journal of Cardiology|January 12, 2005
New predictors of outcome in idiopathic pulmonary arterial hypertensionSteven M Kawut, Evelyn M Horn, Ketevan K Berekashvili, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated evidence-based treatment algorithm in pulmonary arterial hypertensionRobyn J Barst, J Simon R Gibbs, Hossein A Ghofrani, et al.
Pageof 14